Security Snapshot

GSK plc - Ordinary Shares and American Depositary Shares (GSK) Institutional Ownership

CUSIP: 37733W204

13F Institutional Holders and Ownership History from Q1 2016 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

785

Shares (Excl. Options)

213.11MFull value: 213,108,105 · shares · 30 Sep 2026

Price

$48.17

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.01%
Share change
-6,905,310
Value change
-$352,234,592
Number of holders
785
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
4,029,280,651
SEC-reported price per share
$48.74
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • GSK - GSK plc - Ordinary Shares and American Depositary Shares is tracked under CUSIP 37733W204.
  • 785 institutions reported positions in Q3 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 1,045 to 785 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $18.17BFull value: $18,166,390,301 · USD · 30 Jun 2026
    to
    $10.27BFull value: $10,272,586,047 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 785 institutions filings for Q3 2026.

Open SEC evidence

Security key

37733W204

13F reference period

Q3 2026

13F holders

785

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
GSK
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DODGE & COX 4.3% $9,090,903,298 173,259,068 Dodge & Cox 30 Jun 2026
As of 30 Sep 2026, 785 institutional investors reported holding
213.11MFull value: 213,108,105 · shares · 30 Sep 2026
shares of GSK plc - Ordinary Shares and American Depositary Shares (GSK). This represents 5.3% of the company’s total
4.03BFull value: 4,029,280,651 · shares · Stored outstanding share count
outstanding shares.

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
43
Headline period
Q3 2026
Rows shown
1-25 of 43
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 213,108,105 $10,272,586,047 -$352,234,592 $48.17 785
2026 Q2 346,570,775 $18,166,390,301 -$1,463,610,727 $52.42 1,045
2026 Q1 374,190,532 $20,653,072,044 -$1,226,601,157 $55.19 1,031
2025 Q4 397,707,646 $19,505,789,840 +$560,994,497 $49.04 990
2025 Q3 385,810,445 $16,653,456,346 +$149,628,861 $43.16 883
2025 Q2 377,323,511 $14,492,600,704 +$691,641,935 $38.40 873
2025 Q1 365,061,086 $14,138,125,686 +$1,006,993,911 $38.74 839
2024 Q4 340,917,752 $11,541,588,389 +$1,180,300,325 $33.82 833
2024 Q3 302,968,498 $12,377,977,607 -$140,106,119 $40.88 883
2024 Q2 309,126,756 $11,909,339,872 -$23,346,819 $38.50 869
2024 Q1 308,583,941 $13,222,947,461 +$833,173,631 $42.87 891
2023 Q4 289,484,844 $10,732,131,887 +$174,194,109 $37.06 882
2023 Q3 284,245,298 $10,307,406,122 +$264,432,361 $36.25 835
2023 Q2 276,495,626 $9,857,311,052 +$194,467,459 $35.64 814
2023 Q1 269,710,676 $9,600,329,935 -$208,079,525 $35.58 792
2022 Q4 276,203,256 $9,708,565,984 +$516,369,806 $35.14 788
2022 Q3 264,324,002 $7,785,299,734 +$7,652,922,694 $29.43 697
2022 Q2 4,250,301 $185,367,037 +$183,087,502 $43.53 67
2022 Q1 52,302 $2,281,067 -$356,058 $43.56 7
2021 Q4 60,336 $2,667,168 -$139,973 $44.10 7
2021 Q3 17,405 $671,931 +$7,790 $38.21 6
2021 Q2 17,188 $691,875 -$30,222 $39.82 6
2021 Q1 17,949 $649,577 +$393,265 $35.69 6
2020 Q4 7,178 $264,151 -$29,072 $36.80 4
2020 Q3 7,968 $299,261 +$325 $37.64 4
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .